UB Paderborn / Katalog / Suche / in CDI

Mathematical Modeling of the in Vitro Hepatic Disposition of Mycophenolic Acid and Its Glucuronide in Sandwich-Cultured Human Hepatocytes

Molecular pharmaceutics, 2014-02, Vol.11 (2), p.568-579

2014

Volltextzugriff (PDF)

Modeling approach for multiple transporters-mediated drug–drug interactions in sandwich-cultured human hepatocytes: Effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide

Drug metabolism and pharmacokinetics, 2015-04, Vol.30 (2), p.142-148

2015

Volltextzugriff (PDF)

Evaluation of hepatic disposition of paroxetine using sandwich-cultured rat and human hepatocytes

Drug metabolism and disposition, 2013-04, Vol.41 (4), p.735

2013

Volltextzugriff (PDF)

Statistical Study of Clathrate-Hydrate Nucleation in a Water/Hydrochlorofluorocarbon System: Search for the Nature of the “Memory Effect”

The journal of physical chemistry. B, 2003-06, Vol.107 (22), p.5289-5293

2003

Volltextzugriff (PDF)

Population Pharmacokinetics and Exposure–response Relationship of a Muscarinic Receptor Antagonist, Imidafenacin

DRUG METABOLISM AND PHARMACOKINETICS, 2013, Vol.28 (3), p.203-212

2013

Volltextzugriff (PDF)

Modeling and simulation of bone mineral density response from a phase 2 study of ONO-5334, a new cathepsin K inhibitor, to support dose selection in osteoporosis

Journal of clinical pharmacology, 2014-08, Vol.54 (8), p.937-948

2014

Volltextzugriff (PDF)

Population pharmacokinetic and pharmacodynamic modeling of different formulations of ONO-5334, cathepsin K inhibitor, in Caucasian and Japanese postmenopausal females

Journal of clinical pharmacology, 2014-01, Vol.54 (1), p.23-34

2014

Volltextzugriff (PDF)

Impact of “Guidance for Industry: Clinical Pharmacokinetic Studies of Pharmaceuticals” on New Drug Approvals of Central Nervous System Drugs in Japan

DRUG METABOLISM AND PHARMACOKINETICS, 2011-01, Vol.26 (1), p.117-120

2011

Volltextzugriff (PDF)

The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling

Biopharmaceutics & drug disposition, 2010-10, Vol.31 (7), p.396-406

2010

Volltextzugriff (PDF)

Response to “Suspected Differential Interactions of Digoxin with Imidafenacin and Propantheline; Some Thoughts for Introspection”

Drug metabolism and pharmacokinetics, 2009-01, Vol.24 (5), p.486-487

2009

Volltextzugriff (PDF)

Response to “Suspected Differential Interactions of Digoxin with Imidafenacin and Propantheline; Some Thoughts for Introspection”

DRUG METABOLISM AND PHARMACOKINETICS, 2009, Vol.24 (5), p.486-487

2009

Volltextzugriff (PDF)

Erratum: In Vitro Metabolism and Inhibitory Effects of Pranlukast in Human Liver Microsomes [Biol. Pharm. Bull. 32(4): 688-693 (2009)]

Biological and Pharmaceutical Bulletin, 2009/07/01, Vol.32(7), pp.1311-1311

2009

Volltextzugriff (PDF)

Design and Synthesis of a Highly Selective EP2-Receptor Agonist

Bioorganic & medicinal chemistry letters, 2001-08, Vol.11 (15), p.2025-2028

2001

Volltextzugriff (PDF)

A Survey of Clinical Pharmacokinetic Studies of 17 Cardiovascular Drugs in Japanese New Drug Approvals Between 2000 and 2007

臨床薬理, 2009, Vol.40(6), pp.287-293

2009

Volltextzugriff (PDF)

Agent-Based Simulation for Analyzing Network Formation with Learning Dynamics

数学和系统科学：英文版, 2012, Vol.2 (9), p.576-585

Michiharu Masui Mikio Ogawa

2012

Volltextzugriff (PDF)

Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives

Bioorganic & medicinal chemistry, 2002-04, Vol.10 (4), p.1093-1106

2002

Volltextzugriff (PDF)

Development and validation of an on‐line two‐dimensional reversed‐phase liquid chromatography–tandem mass spectrometry method for the simultaneous determination of prostaglandins E 2 and F 2 α and 13,14‐dihydro‐15‐keto prostaglandin F 2α levels in human plasma

Biomedical chromatography, 2009-03, Vol.23 (3), p.315-323

2009

Volltextzugriff (PDF)

Erratum: In Vitro Metabolism and Inhibitory Effects of Pranlukast in Human Liver Microsomes[Biol. Pharm. Bull. 32(4)

Biological & pharmaceutical bulletin, 2009-07, Vol.32 (7)

2009

Volltextzugriff (PDF)

Development and validation of an on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry method for the simultaneous determination of prostaglandins E2 and F2α and 13,14-dihydro-15-keto prostaglandin F2α levels in human plasma

Biomedical chromatography, 2009-03, Vol.23 (3), p.315-323

2009

Volltextzugriff (PDF)

The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice

Biomedical Research, 1985/04/01, Vol.6(2), pp.103-105

1985

Volltextzugriff (PDF)

Development and validation of an on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry method for the simultaneous determination of prostaglandins E(2) and F(2alpha) and 13,14-dihydro-15-keto prostaglandin F(2alpha) levels in human plasma

Biomedical chromatography, 2009-03, Vol.23 (3), p.315-323

2009

Volltextzugriff (PDF)

Prospective postsurgical capsule endoscopy in patients with Crohn’s disease

World journal of gastrointestinal endoscopy, 2014-03, Vol.6 (3), p.88-98

2014

Volltextzugriff (PDF)

Development of a highly selective EP2-receptor agonist. Part 2: identification of 16-Hydroxy-17,17-trimethylene 9β-chloro PGF derivatives

Bioorganic & medicinal chemistry, 2002-04, Vol.10 (4), p.1107-1114

2002

Volltextzugriff (PDF)

Inhibitory effects of prostaglandin E1.alpha-cyclodextrin (PGE1.CD) on dimethylnitrosamine-induced acute liver damage in rats

Nihon yakurigaku zasshi, 1995-04, Vol.105 (4), p.221-229

1995

Volltextzugriff (PDF)

A Practical Synthesis and Biological Evaluation of 9-Halogenated PGF Analogues

Bioorganic & medicinal chemistry, 2002-06, Vol.10 (6), p.1883-1894

2002

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Mathematical Modeling of the in Vitro Hepatic Disposition of Mycophenolic Acid and Its Glucuronide in Sandwich-Cultured Human Hepatocytes

Modeling approach for multiple transporters-mediated drug–drug interactions in sandwich-cultured human hepatocytes: Effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide

Evaluation of hepatic disposition of paroxetine using sandwich-cultured rat and human hepatocytes

Statistical Study of Clathrate-Hydrate Nucleation in a Water/Hydrochlorofluorocarbon System: Search for the Nature of the “Memory Effect”

Population Pharmacokinetics and Exposure–response Relationship of a Muscarinic Receptor Antagonist, Imidafenacin

Modeling and simulation of bone mineral density response from a phase 2 study of ONO-5334, a new cathepsin K inhibitor, to support dose selection in osteoporosis

Population pharmacokinetic and pharmacodynamic modeling of different formulations of ONO-5334, cathepsin K inhibitor, in Caucasian and Japanese postmenopausal females

Impact of “Guidance for Industry: Clinical Pharmacokinetic Studies of Pharmaceuticals” on New Drug Approvals of Central Nervous System Drugs in Japan

The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling

Response to “Suspected Differential Interactions of Digoxin with Imidafenacin and Propantheline; Some Thoughts for Introspection”

Response to “Suspected Differential Interactions of Digoxin with Imidafenacin and Propantheline; Some Thoughts for Introspection”

Erratum: In Vitro Metabolism and Inhibitory Effects of Pranlukast in Human Liver Microsomes [Biol. Pharm. Bull. 32(4): 688-693 (2009)]

Design and Synthesis of a Highly Selective EP2-Receptor Agonist

A Survey of Clinical Pharmacokinetic Studies of 17 Cardiovascular Drugs in Japanese New Drug Approvals Between 2000 and 2007

Agent-Based Simulation for Analyzing Network Formation with Learning Dynamics

Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives

Development and validation of an on‐line two‐dimensional reversed‐phase liquid chromatography–tandem mass spectrometry method for the simultaneous determination of prostaglandins E 2 and F 2 α and 13,14‐dihydro‐15‐keto prostaglandin F 2α levels in human plasma

Erratum: In Vitro Metabolism and Inhibitory Effects of Pranlukast in Human Liver Microsomes[Biol. Pharm. Bull. 32(4)

Development and validation of an on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry method for the simultaneous determination of prostaglandins E2 and F2α and 13,14-dihydro-15-keto prostaglandin F2α levels in human plasma

The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice

Development and validation of an on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometry method for the simultaneous determination of prostaglandins E(2) and F(2alpha) and 13,14-dihydro-15-keto prostaglandin F(2alpha) levels in human plasma

Prospective postsurgical capsule endoscopy in patients with Crohn’s disease

Development of a highly selective EP2-receptor agonist. Part 2: identification of 16-Hydroxy-17,17-trimethylene 9β-chloro PGF derivatives

Inhibitory effects of prostaglandin E1.alpha-cyclodextrin (PGE1.CD) on dimethylnitrosamine-induced acute liver damage in rats

A Practical Synthesis and Biological Evaluation of 9-Halogenated PGF Analogues

Suchergebnisse filtern